Pfizer wins $10 billion bidding war for Metsera
By X-blogger - on November 10, 2025
U.S. drugmaker Pfizer has clinched a $10 billion deal for obesity drug developer Metsera, capping a fierce biotech bidding war between the New York-based pharma giant and Danish rival Novo Nordisk.
Write a comment
No comments yet, Be the first!
Special Offer
First Deposit BonusFirst Deposit Bonus | Phone Verification | First Trade on us | Account Verification












